BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11724989)

  • 1. Recurrent transfusion-related acute lung injury.
    Win N; Montgomery J; Sage D; Street M; Duncan J; Lucas G
    Transfusion; 2001 Nov; 41(11):1421-5. PubMed ID: 11724989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study.
    Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR
    Transfusion; 1997 Jul; 37(7):719-26. PubMed ID: 9225936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura.
    Van Buren NL; Stroncek DF; Clay ME; McCullough J; Dalmasso AP
    Transfusion; 1990 Jan; 30(1):42-5. PubMed ID: 2296790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating transfusion-related acute lung injury (TRALI).
    Fung YL; Goodison KA; Wong JK; Minchinton RM
    Intern Med J; 2003 Jul; 33(7):286-90. PubMed ID: 12823673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities.
    Davoren A; Curtis BR; Shulman IA; Mohrbacher AF; Bux J; Kwiatkowska BJ; McFarland JG; Aster RH
    Transfusion; 2003 May; 43(5):641-5. PubMed ID: 12702187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood.
    Bux J; Becker F; Seeger W; Kilpatrick D; Chapman J; Waters A
    Br J Haematol; 1996 Jun; 93(3):707-13. PubMed ID: 8652399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004.
    Dunn P; Dinesh D
    N Z Med J; 2008 Jun; 121(1276):42-7. PubMed ID: 18574508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-related acute lung injury: current concepts for the clinician.
    Triulzi DJ
    Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria.
    ZupaƄska B; Uhrynowska M; Konopka L
    Transfusion; 1999 Sep; 39(9):944-7. PubMed ID: 10533819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent transfusion-related acute lung injury after a two-year interval.
    Krochmal JD; Dwyre DM; Swanson KM; Raife TJ; Schlueter AJ
    Transfus Med; 2007 Jun; 17(3):192-6. PubMed ID: 17561861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related acute lung injury (TRALI) after fresh frozen plasma in a patient with coagulopathy.
    Lindgren L; Yli-Hankala A; Halme L; Koskimies S; Orko R
    Acta Anaesthesiol Scand; 1996 May; 40(5):641-4. PubMed ID: 8792898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe transfusion-related acute lung injury.
    Brander L; Reil A; Bux J; Taleghani BM; Regli B; Takala J
    Anesth Analg; 2005 Aug; 101(2):499-501. PubMed ID: 16037167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we underestimating reverse TRALI?
    De Clippel D; Emonds MP; Compernolle V
    Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single hospital experience of TRALI.
    Wallis JP; Lubenko A; Wells AW; Chapman CE
    Transfusion; 2003 Aug; 43(8):1053-9. PubMed ID: 12869110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.